CURE adds Richard Serbin to advisory board
CURE Pharmaceutical, a developer and manufacturer of advanced oral thin film for use in pharmaceutical, veterinary, and buccal and dermal over-the-counter applications, has announced the appointment of Richard Serbin to its advisory board.
“Richard has impressive and extensive experience as management, regulatory and intellectual property counsel and various operational roles throughout the pharmaceutical industry,” said Rob Davidson, CEO of CURE Pharmaceutical. “We are very fortunate to count him among our trusted advisors and look forward to the benefit he brings to CURE.”
Richard S. Serbin currently serves as the president of Corporate Development and in-house legal counsel at Life Science Institute. Serbin is a global strategy advisor and entrepreneur with credentials both in pharmacy and law, complemented by more than 40 years of service as an FDA regulatory attorney and patent attorney in the healthcare industry. Serbin is an expert in licensing medical extracts, compounds, and technologies. He is a pharmacist and patent attorney with more than 25 years of experience in the pharmaceutical industry and the investment community. Founder of Radius Scientific, he also served as chief executive officer of Optigenex and president of Bradley Pharmaceuticals, and in multiple capacities at Ortho Pharmaceuticals, a Johnson & Johnson subsidiary, Revlon and Schering-Plough. In addition, he served as a consultant to various pharmaceutical companies.
Serbin served on the board of directors of 16 U.S. and international subsidiary companies for Johnson & Johnson, including Ethicon, Ortho, J&J Consumer Products, Pittman-Moore, Mc Neil, and J&J Development. He served as director at Viropro, Rapid Nutrition and Optigenex.
Serbin plays an active role in developing business strategy and joint venture contacts and in guiding Mazal Plant Pharmaceuticals in regulatory compliance and investor relations. He worked on multiple international acquisitions and strategic relationships, and sat on the Board of Directors of several of its international subsidiaries, including those in India, Hong Kong, Japan, Taiwan, Germany and England. He has been head of its Business Advisory Board. In addition, for the last 10 years, Serbin has been a senior advisor to the Swedish American Life Science Summit (SALSS), held annually in Stockholm, Sweden.